Amicus Therapeutics Inc FOLD

Amicus Therapeutics is an American healthcare company founded in 2002, with its headquarters in Cranbury, New Jersey. The company is a global biotech organisation engaged in the discovery, development, and delivery of therapies treating a range of rare metabolic diseases. Amicus is a highly patient-centric organisation, dedicated to supporting patients across the world who are living with many rare and often chronic diseases.

Amicus Therapeutics stock is traded on the NASDAQ GM under the symbol FOLD. In October 2020, the FOLD price chart was showing a 52-week low of $6.25 and a 52-week high of $16.13, with a market cap of $3.49bn.

The company has developed various life-changing therapies, such as Galafold® — an orally-administered small molecule pharmacological chaperone for the treatment of Fabry disease. Amicus is highly involved in patient advocacy — providing information on rare diseases, raising awareness, and running patient advisory boards to enhance understanding of the patient community and gain insight from those whose daily lives are affected by rare diseases. In addition, the company is involved in supporting professional non-profit organisations — providing programs, services, and activities aimed at enhancing the lives of those living with rare diseases.

Interested in monitoring the FOLD price chart for news and updates? Add this instrument to your eToro watchlist.